Testing effectiveness (Phase 2)Ended earlyNCT00910039
What this trial is testing
Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases
Who this might be right for
Cognitive/Functional EffectsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 14